SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,783,099 | +6.2% | 59,318 | +28.0% | 0.01% | -14.3% |
| Q1 2023 | $1,678,391 | +46.2% | 46,326 | +44.0% | 0.01% | +16.7% |
| Q4 2022 | $1,147,682 | +120.7% | 32,175 | +109.3% | 0.01% | +100.0% |
| Q3 2022 | $520,000 | -65.5% | 15,369 | -70.3% | 0.00% | -75.0% |
| Q4 2021 | $1,509,000 | +506.0% | 51,750 | +394.1% | 0.01% | +200.0% |
| Q2 2020 | $249,000 | +29.7% | 10,474 | -2.1% | 0.00% | -50.0% |
| Q1 2020 | $192,000 | -77.0% | 10,699 | -69.7% | 0.01% | -69.2% |
| Q4 2019 | $836,000 | – | 35,262 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |